You are here

CDUHR Weekly Update - September 30, 2019


AIDS Seminar
HCV/HIV prevalence, risk, and care among persons who inject drugs in upstate New York
Eli Rosenberg, PhD - SUNY University at Albany
Tuesday, October 8, 10:30-11:30am
715 Broadway, Floor 12, Room 1221
Find more information HERE

Health Economics Training
Expanding the Impact of Substance Use Disorder Research: Economic Analysis for Program and Policy Evaluation
Jake Morgan, PhD - Boston University
Thursday, October 24, 10:00am-1:00pm
715 Broadway, Floor 12, Room 1221
Lunch will be provided, registration is required
Find more information and register HERE

Chatty Wednesday Research Forum Series
Giving Men a Voice (GMaV)
Ellen Benoit, PhD - North Jersey Community Research Initiative
Revisiting Data to Ask New Questions
Ian David Aronson, PhD - NYU GPH
Wednesday, October 30, 12:00-1:30pm
665 Broadway, Floor 11, Room 1111
Lunch will be provided, registration is required Find more information and register HERE


HIV Center Rounds
Using ARV Drug Levels in Dried-Blood Spot Samples to Manage ART Adherence in South Africa
Robert Remien, PhD - Columbia University
PrEP and Opioid Use Services in STI Clinics and Community-Based Organizations: An Implementation Study
Susan Tross, PhD - Columbia University
Thursday, October 3, 9:30-11:00am
NYS Psychiatric Institute, 1051 Riverside Drive, Room 6602
Find more information HERE

Youth Prevention Research Working Group Webinar
Exploring and Disrupting Pathways to Risky Behaviors
Diana H. Fishbein, PhD - Penn State & Kevin P. Haggerty, MSW, PhD - Univ of Washington
Wednesday, October 16, 1:00-2:00pm
Find more information and register HERE

NYC DOHMH Health Briefing
Chemsex and Crystal Meth Use among LGBTQ+ Communities in New York City
Jorge Ochoa
Friday, October 18, 4:30-6:00pm
NYU, 726 Broadway, Room 701
Find more information and register HERE

Health Disparities Symposium
Thursday, October 24, 8:00am-5:15pm
550 First Avenue, Farkas Auditorium
Find more information and register HERE

Special HIV Center Rounds
Staying at Zero: The Role of Social Science in Ending the HIV Epidemic
Judith Auerbach, PhD - UCSF
Thursday, October 24, 9:30am-1:00pm
The presentation will be followed by a panel of experts moderated by Dr. Quarraisha Abdool Karim. Breakfast will be served and RSVP requested.
Find more information HERE


The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
The purpose of this FOA is to invite R01 applications on the influence and intersection of sex and gender in health and disease including: (1) research applications that examine sex and gender factors and their intersection in understanding health and disease; and (2) research that addresses one of the five objectives from Strategic Goal 1 of the new 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women."

Tobacco Regulatory Science (R01 Clinical Trial Optional)
The purpose of this FOA is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).


Danie Ompad was quoted in a piece from amNewYork, Ban on Preemployment Marijuana Testing to Impact HR Policies Nationwide, Experts Say.

Brett Wolfson-Stofko was quoted in a piece from Marketplace, The Opioid Epidemic is Killing Americans at Work, and Employers are Taking Notice.


Akiyama MJ, Cleland CM, Lizcano JA, Cherutich P, & Kurth AE (2019) Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study. The Lancet Infectious Diseases, doi: 10.1016/S1473-3099(19)30264-6. Find the abstract on the publisher's website HERE.

Bradley ELP, Lanier Y, Ukuku Miller AM, Brawner BM, & Sutton MY (2019) Successfully recruiting Black and Hispanic/Latino adolescents for sexually transmitted infection and HIV prevention research. Journal of Racial and Ethnic Health Disparities, doi: 10.1007/s40615-019-00631-7. Find the abstract on the publisher's website HERE.

Griffin M, Callander D, Duncan DT, & Palamar JJ (2019) Differential risk for drug use by sexual minority status among electronic dance music party attendees in New York City. Substance Use and Misuse, doi: 10.1080/10826084.2019.1662811. Find the abstract on the publisher's website HERE.


Annual Conference on the Science of Dissemination and Implementation in Health
Raising the Bar on the Rigor, Relevance, and Rapidity of Dissemination and Implementation Science
December 4-6 - Arlington, VA
Early registration prices through October 7


Hudson River HealthCare is currently seeking a full-time Harm Reduction Education Coordinator (HREC) to join their team in Poughkeepsie to work on the Rural Overdose Disparities Project (Rural OD Project). The project goals are to connect individuals at risk of overdose and other drugs use related harms with life-saving harm reduction supplies and education, and link to medication assisted treatment (MAT); to build behavioral health and harm reduction service capacity through coordinating a professional education curriculum targeting members of the Dutchess County Opioid Task Force and to collect needs assessment data through field work. It also involves developing monthly harm reduction-focused education for the county's Opioid Task Force. Find the full announcement HERE.

The Temple University College of Public Health announced a Postdoctoral Scholar position for a quantitative methodologist working in the following areas: infectious disease and social epidemiology, network science, spatial analyses, and computational modeling/simulation. The substantive focus will be on HIV and substance use disorders. The position is under the direct supervision of Dr. Abby Rudolph PhD, MPH in the Department of Epidemiology and Biostatistics in the College of Public Health at Temple University, an urban, research-intensive R1 university located in Philadelphia, a city rich in history, culture and diversity. Find the full announcement HERE.

The K12 Career Development Program in Substance Use and Addiction Medicine, based at Massachusetts General Hospital is recruiting post-doctoral clinician-scientists. It aims to provide scholars with a concentrated research experience, mentorship, and advanced training to prepare them for leadership in addiction medicine through independent research careers in academics or industry or influential positions in government. Eligible applicants will have completed doctoral-level training in a clinical discipline (MD, PhD or equivalent). Find the full announcement HERE.